Citation Impact
Citing Papers
Faecal diversion for Crohn's colitis: a model to study the role of the faecal stream in the inflammatory process.
1994
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Parenteral Anticoagulants
2008
Parenteral Anticoagulants
2012 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2008 Standout
Inflammation and Alzheimer's disease
2000 Standout
Beyond water activity: Recent advances based on an alternative approach to the assessment of food quality and safety
1991 Standout
Predicting the presence of plasma heparin using neural networks to analyze coagulation screening assay optical profiles
1996
Health status in inflammatory bowel disease
1990
INR calibration of Owren-type prothrombin time based on the relationship between PT% and INR utilizing normal plasma samples
2004 StandoutNobel
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
Photodynamic Therapy
1998 Standout
Recurrent Venous Thromboembolism After Deep Vein Thrombosis
2000
Foreign body reaction to biomaterials
2008 Standout
On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies
2008
Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? The LInköping Study on Thrombosis (LIST) – A 7-year follow-up
2012 StandoutNobel
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Has the Quick or the Owren prothrombin time method the advantage in harmonization for the International Normalized Ratio system?
2002
Perioperative Management of Antithrombotic Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
The immediate and long-term effects of postoperative total parenteral nutrition on body composition
1987
Heparin Thromboprophylaxis in Gastric Bypass Surgery
2003
Subcutaneous Low-Molecular-Weight Heparin Compared with Continuous Intravenous Heparin in the Treatment of Proximal-Vein Thrombosis
1992 Standout
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2004 Standout
Colonoscopy of acute colitis
1994
Multiple sclerosis
2008 Standout
Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease
2006 Standout
Prospective study on the relationship between infections and multiple sclerosis exacerbations
2002
Antithrombotic Therapy for VTE Disease
2012 Standout
Inflammatory Bowel Disease
1991 Standout
Plasmonic photothermal therapy (PPTT) using gold nanoparticles
2007 Standout
Ulcerative colitis
2012 Standout
Heparin and Low-Molecular-Weight Heparin
2004
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Comparison of Anti–Factor Xa Heparin Activity and Activated Partial Thromboplastin Time in 2,773 Plasma Samples From Unfractionated Heparin–Treated Patients
1997
Prevention of VTE in Nonorthopedic Surgical Patients
2012 Standout
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
2012 Standout
Prevention of Venous Thromboembolism
2004 Standout
Heparin and Low-Molecular-Weight Heparin
1998
A Prospective Multivariate Analysis of Clinical Factors Associated With Pouchitis After Ileal Pouch–Anal Anastomosis
2007
Heparin-induced thrombocytopenia and cardiac surgery
2003 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
A Novel Method of Natural Cryoprotection
1985
Prevention of Venous Thromboembolism
2008 Standout
Ulcerative colitis
2020 Standout
A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa
2013
Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparin
1990
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Review of the biology of quercetin and related bioflavonoids
1995 Standout
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials
2003 Standout
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
The Phagosome: Compartment with a License to Kill
2007
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Blood plasma coagulation studied by surface plasmon resonance
2000 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2004 Standout
The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram
1993
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Flow cytometry: Rapid biochemical analysis of single cells
1982
Colonoscopy in inflammatory bowel disease
1987
Postoperative complications in colorectal surgery in relation to preoperative clinical and nutritional state and postoperative nutritional treatment
1987
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Thrornboxanes in inflammatory bowel disease—pathogenic and therapeutic implications
1993
Nile red: a selective fluorescent stain for intracellular lipid droplets.
1985 Standout
Indium-111-labeled leukocytes for the detection of infection: Current status
1994
Predictors of acute relapse of Crohn's disease
1987
The Epidemiology of Venous Thromboembolism
2003 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Low-Molecular-Weight Heparins
1997 Standout
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Skin Testing and Erythrocyte Sedimentation Rate in Women Undergoing Breast Biopsy
1984
PORPHYRIN PHOTOSENSITIZATION AND PHOTOTHERAPY
1986
Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells
1994
Anticoagulants and Thrombolytics
1991
Assessment of disease activity in inflammatory bowel disease; relevance for clinical trials.
2003
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance
1992
Works of Ingebrigt Talstad being referenced
Which Coagulation Factors Interfere with the One-Stage Prothrombin Time?
1993
Incomplete Reversal of Enoxaparin-Induced Bleeding by Protamine Sulfate
1991
Why Is the Standardization of Prothrombin Time a Problem?
2000
Multicenter studies of ultra-high-dose, short-duration streptokinase treatment of deep vein thrombosis
1996
Sequential Flow Cytometric Analysis of Cellular DNA‐Content in Peripheral Blood during Treatment for Acute Leukaemia
1979
The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models
1979
Patterns in quench-frozen, freeze-dried, blood proteins.
1981
Light-induced release of protoporphyrin, but not of zinc protoporphyrin, from erythrocytes in a patient with greatly elevated erythrocyte protoporphyrin
1983
PROTECTION OF BLOOD CELLS BY PLASMA PROTEINS
1971
Degranulation and enzyme release during phagocytosis of inert particles and of bacteria by polymorphonuclear neutrophil granulocytes.
1983
The Disease Activity of Ulcerative Colitis and Crohn’s Disease
1976
Heparin Therapy Adjusted for Body Weight
1985
Thrombocytosis in Ulcerative Colitis and Crohn’s Disease
1973
In Vitro Release of Lysozyme From Monocytes and Granulocytes
1984